Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drugD S Alberts, A V Hallum, M Stratton-Custis, et al.
Genes, Chromosomes & Cancer|June 24, 1999
Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 casesR Taetle, M Aickin, J M Yang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group studyH O Smith, C S Jiang, G R Weiss, et al.
Gynecologic Oncology|October 31, 2006
Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancerD S Alberts, M Markman, F Muggia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Clinical pharmacology of a novel diarylsulfonylurea anticancer agentC W Taylor, D S Alberts, M A Ketcham, et al.
Gynecologic Oncology|February 1, 1987
Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group StudyD S Alberts, N L Mason, R V O'Toole, et al.
The New England Journal of Medicine|December 26, 1996
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancerD S Alberts, P Y Liu, E V Hannigan, et al.
Gynecologic Oncology|January 15, 1999
13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trialG R Weiss, P Y Liu, D S Alberts, et al.
Technology in Cancer Research & Treatment|December 4, 2003
Investigating sun-damaged skin and actinic keratosis with optical coherence tomography: a pilot studyJ K Barton, K W Gossage, W Xu, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer InstituteG J Kelloff, J A Crowell, C W Boone, et al.
Pageof 32